Cumulative Risk of Guillain–Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic

Objectives. We sought to assess risk of Guillain–Barré syndrome (GBS) among influenza A (H1N1) 2009 monovalent (pH1N1) vaccinated and unvaccinated populations at the end of the 2009 pandemic. Methods. We applied GBS surveillance data from a US population catchment area of 45 million from October 15, 2009, through May 31, 2010. GBS cases meeting Brighton Collaboration criteria were included. We calculated the incidence density ratio (IDR) among pH1N1 vaccinated and unvaccinated populations. We also estimated cumulative GBS risk using life table analysis. Additionally, we used vaccine coverage data and census population estimates to calculate denominators. Results. There were 392 GBS cases; 64 (16%) occurred after pH1N1vaccination. The vaccinated population had lower average risk (IDR = 0.83, 95% confidence interval = 0.63, 1.08) and lower cumulative risk (6.6 vs 9.2 cases per million persons, P = .012) of GBS. Conclusions. Our findings suggest that at the end of the influenza season cumulative GBS risk was less among the pH1N1vaccinated than the unvaccinated population, suggesting the benefit of vaccination as it relates to GBS. The observed potential protective effect on GBS attributed to vaccination warrants further study

Confidence interval · Coronavirus disease 2019 (COVID-19) · Cumulative incidence · Disease · Environmental health · Guillain-Barre syndrome · Human mortality from H5N1 · Incidence (geometry) · Infectious disease (medical specialty) · Pandemic · Population · Relative risk · Vaccination · Demography · Infectious Encephalopathies and Encephalitis · Influenza Virus Research Studies · Internal Medicine · Medicine · Peripheral Neuropathies and Disorders · Virology · Pediatrics

• Do Vaccines Have a Role as a Cause of Autoimmune Neurological Syndromes

  Open Access•Nicola Principi, Susanna Esposito•Frontiers in Public Health•2020

  Add to list